首页> 外文期刊>Cell death and differentiation >ASPP2 deficiency causes features of 1q41q42 microdeletion syndrome
【24h】

ASPP2 deficiency causes features of 1q41q42 microdeletion syndrome

机译:ASPP2缺乏导致1q41q42微缺失综合征的特征

获取原文
获取原文并翻译 | 示例
           

摘要

Chromosomal abnormalities are implicated in a substantial number of human developmental syndromes, but for many such disorders little is known about the causative genes. The recently described 1q41q42 microdeletion syndrome is characterized by characteristic dysmorphic features, intellectual disability and brain morphological abnormalities, but the precise genetic basis for these abnormalities remains unknown. Here, our detailed analysis of the genetic abnormalities of 1q41q42 microdeletion cases identified TP53BP2, which encodes apoptosis-stimulating protein of p53 2 (ASPP2), as a candidate gene for brain abnormalities. Consistent with this, Trp53bp2-deficient mice show dilation of lateral ventricles resembling the phenotype of 1q41q42 microdeletion patients. Trp53bp2 deficiency causes 100% neonatal lethality in the C57BL/6 background associated with a high incidence of neural tube defects and a range of developmental abnormalities such as congenital heart defects, coloboma, microphthalmia, urogenital and craniofacial abnormalities. Interestingly, abnormalities show a high degree of overlap with 1q41q42 microdeletion-associated abnormalities. These findings identify TP53BP2 as a strong candidate causative gene for central nervous system (CNS) defects in 1q41q42 microdeletion syndrome, and open new avenues for investigation of the mechanisms underlying CNS abnormalities.
机译:染色体异常与许多人类发育综合症有关,但是对于许多此类疾病,人们对致病基因了解甚少。最近描述的1q41q42微缺失综合症的特征在于特征性的畸形特征,智力残疾和脑形态异常,但这些异常的确切遗传基础仍然未知。在这里,我们对1q41q42微缺失病例的遗传异常的详细分析确定了TP53BP2,它编码p53 2(ASPP2)的促凋亡蛋白,是大脑异常的候选基因。与此一致的是,Trp53bp2缺陷小鼠表现出侧脑室扩张,类似于1q41q42微缺失患者的表型。 Trp53bp2缺乏会在C57BL / 6背景中引起100%的新生儿致死性,与神经管缺陷的高发生率和一系列发育异常有关,例如先天性心脏缺陷,眼球瘤,小眼科,泌尿生殖器和颅面异常。有趣的是,异常显示出与1q41q42微缺失相关的异常高度重叠。这些发现确定TP53BP2是1q41q42微缺失综合症中枢神经系统(CNS)缺陷的强大候选病因基因,并为研究CNS异常的潜在机制开辟了新途径。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号